Pharmaceuticals: one platform for formulation and quality
In pharmaceutical development, a result is only useful when its method, materials, approvals, and audit history can be retrieved with it. When formulation, analytical QC, and product information are managed in separate systems, that context has to be rebuilt whenever a team investigates, changes, reviews, or transfers a product.
Disconnected records slow the work between development and quality. Formulation changes may not carry their full rationale into QC; analytical results may be separated from the batch, method, or specification behind them; and teams spend time proving traceability that a connected record should preserve by default.
Uncountable brings formulation, analytical QC, and PLM together for pharmaceutical and biotech teams on one structured data layer. Teams can keep product knowledge connected across development, testing, change, and release while maintaining GxP-aligned controls, including audit trails, electronic signatures, and validation evidence for each release.
This solution brief is for pharmaceutical R&D, QC, quality, and product-lifecycle leaders who need to improve development speed without compromising controlled, inspection-ready records.
Inside this solution brief:
- How to connect formulation, analytical testing, and product lifecycle data
- Ways to retain traceability from result to method, material, and specification
- The role of audit trails and electronic signatures in controlled workflows
- How quarterly validation kits support a repeatable validation process
- What a shared data layer changes for development-to-quality handoffs
Build a product record that carries its scientific and quality context all the way to release. For more depth, read the GLP-1 reformulation guide.
FAQs
How Uncountable connects pharmaceutical R&D, formulation, quality control, and PLM on one platform, from formulation development through QC batch release, with GxP-aligned traceability throughout.
A validation kit delivered with each platform release, including Installation Qualification (IQ) and Operational Qualification (OQ) already completed, so your team isn't building and executing that documentation from scratch every time.
Formulation data is the recipe: active ingredients, excipients, and process parameters like blend time and compression force. QC release data is the result: assay, impurities, dissolution, and content uniformity, checked against spec. Uncountable keeps both on the same drug-product record, so a release decision is never separated from the formulation and process behind it.
Every change is captured with an automatic audit trail and e-signature, aligned to 21 CFR Part 11 and EU Annex 11 and built for ALCOA+ data integrity, so audit-readiness comes from normal use of the platform rather than a separate compliance effort.
Instrument data flows into LIMS and through to reporting on one platform, standardizing hundreds of analytical methods so labs aren't manually transcribing results between disconnected systems.
